中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 36 Issue 8
Aug.  2020
Turn off MathJax
Article Contents

Efficiency of transient elastography in diagnosis of liver fibrosis in patients with HIV/HCV co-infection

DOI: 10.3969/j.issn.1001-5256.2020.08.011
Research funding:

 

  • Published Date: 2020-08-20
  • Objective To investigate the efficiency of transient elastography(TE) in the diagnosis of liver fibrosis in patients with human immunodeficiency virus(HIV)/hepatitis C virus(HCV) co-infection.Methods The patients with HIV/HCV co-infection who were hospitalized in The Sixth People's Hospital of Xinjiang Uygur Autonomous Region from January 2013 to December 2018 were enrolled and related indices were collected,including routine blood test results,liver function,renal function,coagulation,biochemical parameters for liver fibrosis,and viral load of HIV and HCV.Noninvasive models for liver fibrosis [aspartate aminotransferase-to-platelet ratio index(APRI) and fibrosis-4(FIB-4) ]were calculated,and liver biopsy was performed for all patients.TE was performed within 3 days before biopsy,and the results were expressed as liver stiffness measurement(LSM).A one-way analysis of variance or the Kruskal-Wallis H test was used for comparison between multiple groups;a Spearman correlation analysis was used to investigate the correlation of LSM,APRI,FIB-4,biochemical parameters for liver fibrosis,HCV RNA quantification,and liver biopsy results with the stage of liver fibrosis;the receiver operating characteristic(ROC) curve was used to evaluate the efficiency and cut-off value of LSM in determining the stage of liver fibrosis.Results A total of 76 patients with chronic HCV/HIV co-infection who underwent liver biopsy and were diagnosed with liver fibrosis were enrolled.The correlation analysis showed that LSM had the best correlation with the stage of liver fibrosis(r=0.526,P<0.001)and had a better correlation than APRI(r=0.403,P<0.001) and FIB-4(r=0.441,P<0.001),and among the biochemical parameters for liver fibrosis,only type IV collagen was correlated with the stage of liver fibrosis(r=0.339,P<0.05).HCV RNA quantification had no correlation with the stage of liver fibrosis.For marked liver fibrosis,LSM had an area under the ROC curve of 0.809,0.929,and0.906,respectively,in the diagnosis of S2,S3,and S4 liver fibrosis at the optimal cut-off values of 11.6 k Pa,12.7 k Pa,and 14.5 k Pa,respectively.Conclusion TE can accurately determine the stage of liver fibrosis in patients with HCV/HIV co-infection,which might help to avoid liver biopsy and provide a more reliable basis for developing antiviral regimen and judging the progression of liver fibrosis,and therefore,it holds promise for clinical application.

     

  • loading
  • [1] ZHAO Q,QIN CY,ZHAO ZH,et al. Epigenetic modifications in hepatic stellate cells contribute to liver fibrosis[J]. Tohoku J Exp Med,2013,229(1):35-43.
    [2] FERNNDEZ-RODRGUEZ A,BERENGUER J,JIMNEZSOUSA MA,et al. Prediction of hepatic fibrosis in patients coinfected with HIV and hepatitis C virus based on genetic markers[J]. J Acquir Immune Defic Syndr,2013,64(5):434-442.
    [3] LIN W,WEINBERG EM,CHUNG RT. Pathogenesis of accelerated fibrosis in HIV/HCV co-infection[J]. J Infect Dis,2013,207(Suppl 1):s13-s18.
    [4] FIERER DS,DIETERICH DT,FIEL MI,et al. Rapid progression to decompensated cirrhosis,liver transplant,and death in HIV-infected men after primary hepatitis C virus infection[J]. Clin Infect Dis,2013,56(7):1038-1043.
    [5] DEBES JD,BOHJANEN PR,BOONSTRA A. Mechanisms of accelerated liver fibrosis progression during HIV infection[J].J Clin Transl Hepatol,2016,4(4):328-335.
    [6] FORBES SJ,NEWSOME PN. Liver regeneration-mechanisms and models to clinical application[J]. Nat Rev Gastroenterol Hepatol,2016,13(8):473-485.
    [7] CLAUSEN LN,LUNDBO LF,BENFIELD T. Hepatitis C virus infection in the human immunodeficiency virus infected patient[J]. World J Gastroenterol,2014,20(34):12132-12143.
    [8] CHEN JY,FEENEY ER,CHUNG RT. HCV and HIV co-infection:Mechanisms and management[J]. Nat Rev Gastroenterol Hepatol,2014,11(6):362-371.
    [9] AIDS Professional Group,Society of Infectious Diseases,Chinese Medical Association. Guideline for diagnosis and treatment of HIV/AIDS(2015)[J]. Chin J Clin Infect Dis,2015,8(5):385-401.(in Chinese)中华医学会感染病学分会艾滋病学组.艾滋病诊疗指南(2015版)[J].中华临床感染病杂志,2015,8(5):385-401.
    [10] Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. The guideline of prevention and treatment for hepatitis C:A 2015 update[J]. J Clin Hepatol,2015,31(12):1961-1979.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.丙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1961-1979.
    [11] ARENDS JE,LIEVELD FI,BOEIJEN LL,et al. Natural history and treatment of HCV/HIV coinfection:Is it time to change paradigms?[J]. J Hepatol,2015,63(5):1254-1262.
    [12] KANG F,CHEN W,ZHANG X,et al. Transient liver injury associated with the early recovery of HCV-specific T-cell responses and HCV rebound in HIV-1/HCV coinfected patients undergoing highly active antiretroviral therapy[J]. J Acquir Immune Defic Syndr,2013,62(2):135-142.
    [13] ABDEL ALEM S,ELSHARKAWY A,EL AKEL W,et al. Liver stiffness measurements and FIB-4 are predictors of response to sofosbuvir-based treatment regimens in 7256 chronic HCV patients[J]. Expert Rev Gastroenterol Hepatol,2019,13(10):1009-1016.
    [14] TADA T,KUMADA T,TOYODA H,et al. Improvement of liver stiffness in patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response[J]. J Gastroenterol Hepatol,2017,32(12):1982-1988.
    [15] SINGH S,FACCIORUSSO A,LOOMBA R,et al. Magnitude and kinetics of decrease in liver stiffness after antiviral therapy in patients with chronic hepatitis C:A systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol,2018,16(1):27-38. e4.
    [16] MACAS J,CAMACHO A,von WICHMANN MA,et al. Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients[J]. AIDS,2013,27(16):2541-2549.
    [17] BAILONY MR,SCHERZER R,HUHN G,et al. Association of HIV infection,hepatitis C virus infection,and metabolic factors with liver stiffness measured by transient elastography[J]. J Infect Dis,2013,208(11):1776-1783.
    [18] CHARPENTIER C,CHAMPENOIS K,GERVAIS A,et al. Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients[J]. PLo S One,2013,8(3):e59205.
    [19] WIKTOR S,FORD N,BALL A,et al. HIV and HCV:Distinct infections with important overlapping challenges[J]. J Int AIDS Soc,2014,17:19323.
    [20] NISHITSUJI H,FUNAMI K,SHIMIZU Y,et al. Hepatitis C virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells[J]. J Virol,2013,87(14):8169-8178.
    [21] ZHOU YB,LIANG S,WANG QX,et al. The geographic distribution patterns of HIV-,HCV-and co-infections among drug users in a national methadone maintenance treatment program in Southwest China[J]. BMC Infect Dis,2014,14:134.
    [22] ZHANG F,ZHU H,WU Y,et al. HIV,hepatitis B virus,and hepatitis C virus co-infection in patients in the China national free antiretroviral treatment program,2010-12:A retrospective observational cohort study[J]. Lancet Inf Dis,2014,14(11):1065-1072.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1281) PDF downloads(146) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return